Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in Nigerian men
| Autor: | D Dogo, D N Osegbe, O B Shittu, A A Dikko, A E Aghaji, G C Onyemelukwe |
|---|---|
| Rok vydání: | 2003 |
| Předmět: |
myalgia
Adult Male medicine.medical_specialty Sildenafil Urology medicine.medical_treatment Vasodilator Agents Nigeria Piperazines Sildenafil Citrate chemistry.chemical_compound Erectile Dysfunction Internal medicine Outpatients medicine Humans Sulfones Adverse effect Aged Chemotherapy business.industry Middle Aged medicine.disease Surgery Clinical trial Sexual desire Erectile dysfunction Tolerability chemistry Purines medicine.symptom business |
| Zdroj: | International journal of impotence research. 15 |
| ISSN: | 0955-9930 |
| Popis: | Fifty-eight Nigerian outpatients with documented erectile dysfunction (ED) received open-label sildenafil citrate (Viagra) for 8 weeks. The 50-mg starting dose could be adjusted to 100 or 25 mg based on response and tolerability. The International Index of Erectile Function (IIEF) Questionnaire, a global efficacy question, and intercourse data recorded in a patient event log were used to assess efficacy. Frequency of penetration and maintained erection were both significantly enhanced (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|